Mycophenolate mofetil Recruiting Phase 2 Trials for Immunodeficiency Syndrome / Non-Cancer Diagnosis / Aplastic Anaemia (AA) / Donor / Severe Aplastic Anemia (SAA) Treatment

IndicationsStatusPurposePhase
RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00358657Fludarabine Phosphate, Cyclophosphamide, and Total-Body Irradiation Followed by Donor Bone Marrow Transplant and Cyclophosphamide, Mycophenolate Mofetil, Tacrolimus, and Sirolimus in Treating Patients With Primary Immunodeficiency Disorders or Noncancerous Inherited Disorders
NCT02918292Optimizing Haploidentical Aplastic Anemia Transplantation (BMT CTN 1502)